Utah Medical Products, Inc. Form 8-K August 19, 2005

0001096906-05-000485.txt : 20050822 0001096906-05-000485.hdr.sgml : 20050822 20050822160312 ACCESSION NUMBER: 0001096906-05-000485 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20050819 ITEM INFORMATION: Other Events FILED AS OF DATE: 20050822 DATE AS OF CHANGE: 20050822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: UTAH MEDICAL PRODUCTS INC CENTRAL INDEX KEY: 0000706698 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 870342734 STATE OF INCORPORATION: UT FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-12575 FILM NUMBER: 051041105 BUSINESS ADDRESS: STREET 1: 7043 S 300 WEST CITY: MIDVALE STATE: UT ZIP: 84047 BUSINESS PHONE: 8015661200 8-K 1 utahmed8k081905.htm UTAH MEDICAL PRODUCTS, INC. FORM 8-K AUGUST 19, 2005 Utah Medical Products, Inc. Form 8-K August 19, 2005

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): August 19, 2005

Commission File No. 0-11178

UTAH MEDICAL PRODUCTS, INC.

(Exact name of Registrant as specified in its charter)

UTAH	87-0342734
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

7043 South 300 West

Midvale, Utah 84047

Address of principal executive offices

Registrant's telephone number: (801) 566-1200

ITEM 8.01 OTHER EVENTS

On August 22, 2005, Utah Medical Products, Inc. issued a press release announcing that its FDA trial has been postponed. A copy of the press release is attached hereto as Exhibit 99.1

SIGNATURES

Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	UTAH MEDICAL PRODUCTS, INC.
	REGISTRANT


Date: 8/22/05	By:	/s/ Kevin L. Cornwell
		Kevin L. Cornwell
		CEO

EXHIBIT INDEX

Index
Number	Description

99.1	Press release issued August 22, 2005: FDA Trial Postponed

EX-99.1 2 utahmed8k081905ex99-1.htm EXHIBIT 99.1 Exhibit 99.1

EXHIBIT 99.1

Salt Lake City, Utah - On August 19, 2005, Utah Medical Products, Inc. (Nasdaq:UTMD) received notification that the U.S. District Court in Salt Lake City has postponed the August 30, 2005 beginning date for the trial of the lawsuit filed over a year ago on behalf of the U.S. Food and Drug Administration (FDA) alleging Quality System Regulation (QSR) violations.

The postponement is due to the FDA refusal to reasonably cooperate in the preparation of a proposed mutual pretrial order which describes the specific issues of fact and law which will be the subject of the trial. The parties will meet for another pretrial conference with the Court on August 30, 2005 to attempt to resolve the format of the pretrial order, after which the trial will be rescheduled.

UTMD will request a prompt rescheduling of the trial in an attempt to expedite confirmation of the sufficiency of UTMD procedures relating to the QSR, as these have been managed before and after the August 2004 FDA allegations.

Utah Medical Products, Inc., with particular interest in health care for women and their babies, develops, manufactures, assembles and markets a broad range of well-established, safe and effective, disposable and reusable specialty medical devices.